Now Reading
RxBar, Orgain Founders Raise $312M for Firm Targeting Consumer Wellness Brands

RxBar, Orgain Founders Raise $312M for Firm Targeting Consumer Wellness Brands

Humble Growth is dedicated to the movers and shakers who are upending the status quo in health and wellness goods

Humble Growth, an N.Y.-based growth equity investment firm focusing on visionary consumer brands, has been established by three leading innovators: Andrew Abraham, CEO and creator of Orgain, RxBar founder Peter Rahal and Nick Giannuzzi, a consumer lawyer.

The firm has secured over $312 million for its debut, with notable investors including Nestlé Health Science, Verlinvest, BodyArmor co-founder Mike Repole, Stonyfield Farm founder and CEO Gary Hirshberg, IT Cosmetics co-founder Paulo Lima and Ainsworth Pet Nutrition founder Sean Lang.

“We’re honored to officially launch Humble Growth and work closely with founders to propel their brands to new heights,” Abraham said.

Unlike other newly-launched entities, Humble Growth and its founders aren’t afraid to acknowledge their humble beginnings and failures along their paths to success. 

“We’ve built, scaled and exited our own brands and understand the ongoing challenges founders face when growing their brands firsthand,” said Abraham. “With Humble Growth, we’re taking that knowledge and working alongside founders to support their mission and bring an empathetic perspective to scaling operations.”

Humble Growth will partner with entrepreneurs and brands that promote healthier lifestyles and assist them in entering new growth phases. The trio of founders say their collective experience will be beneficial to entrepreneurs in avoiding the common pitfalls that many experience when starting a business — a touchpoint that Hirshberg wishes he had available years ago.

See Also

“When the idea of Humble Growth began gaining momentum, I was thrilled to jump in as a founding investor,” Hirshberg said. “We are building a true win-win-win model for the investors, the investees and the business. I would have killed to have had a Humble Growth available to support Stonyfield and help bring not only critical funding but also seasoned guidance during our growth years.”

Don Kerrigan, CEO of Nestlé Health Science U.S., noted that the fund is built by transformative founders and includes an impressive lineup of limited partners who are fully immersed in the industry.

“Humble Growth represents one of the most disruptive and coherent investing strategies we have seen in consumer growth,” Kerrigan said.

Scroll To Top